iBio featured on ABC affiliate

iBio Inc.

KXXV, an ABC affiliate in Bryan, Texas, published an article on iBio’s (NYSE AMERICAN:IBIO) two COVID-19 vaccine candidates. 

The company recently reported that it has selected IBIO-201 as its leading candidate for the prevention of SARS-CoV-2 infection, but is still encouraged by the potential of its other vaccine candidate, IBIO-200.

The article can be accessed here.

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.